Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Towards microRNA-based therapeutics for diabetic nephropathy.

Alvarez ML, DiStefano JK.

Diabetologia. 2013 Mar;56(3):444-56. doi: 10.1007/s00125-012-2768-x. Epub 2012 Nov 8.

PMID:
23135222
2.

Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.

DiStefano JK, Taila M, Alvarez ML.

Curr Diab Rep. 2013 Aug;13(4):582-91. doi: 10.1007/s11892-013-0386-8. Review.

PMID:
23666892
3.

The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.

Alvarez ML, Distefano JK.

Diabetes Res Clin Pract. 2013 Jan;99(1):1-11. doi: 10.1016/j.diabres.2012.10.010. Epub 2012 Oct 25. Review.

PMID:
23102915
4.

MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Kato M, Natarajan R.

Ann N Y Acad Sci. 2015 Sep;1353:72-88. doi: 10.1111/nyas.12758. Epub 2015 Apr 15. Review.

5.

MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.

Simpson K, Wonnacott A, Fraser DJ, Bowen T.

Curr Diab Rep. 2016 Mar;16(3):35. doi: 10.1007/s11892-016-0724-8. Review.

6.

Identification of biological targets of therapeutic intervention for diabetic nephropathy with bioinformatics approach.

Wu T, Li Q, Wu T, Liu HY.

Exp Clin Endocrinol Diabetes. 2014 Nov;122(10):587-91. doi: 10.1055/s-0034-1382033. Epub 2014 Jul 8.

PMID:
25003364
7.

In vivo delivery of Gremlin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by recovering bone morphogenetic protein-7.

Zhang Q, Shi Y, Wada J, Malakauskas SM, Liu M, Ren Y, Du C, Duan H, Li Y, Li Y, Zhang Y.

PLoS One. 2010 Jul 22;5(7):e11709. doi: 10.1371/journal.pone.0011709.

8.

Abated microRNA-195 expression protected mesangial cells from apoptosis in early diabetic renal injury in mice.

Chen YQ, Wang XX, Yao XM, Zhang DL, Yang XF, Tian SF, Wang NS.

J Nephrol. 2012 Jul-Aug;25(4):566-76. doi: 10.5301/jn.5000034.

PMID:
21983986
9.

Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.

Kaucsár T, Rácz Z, Hamar P.

Adv Drug Deliv Rev. 2010 Nov 30;62(14):1390-401. doi: 10.1016/j.addr.2010.10.003. Epub 2010 Oct 19. Review.

PMID:
20940025
10.

Diabetic nephropathy-pathophysiology and management.

Shumway JT, Gambert SR.

Int Urol Nephrol. 2002;34(2):257-64. Review.

PMID:
12775108
12.

MicroRNAs in kidney disease: an emerging understanding.

Khella HW, Bakhet M, Lichner Z, Romaschin AD, Jewett MA, Yousef GM.

Am J Kidney Dis. 2013 May;61(5):798-808. doi: 10.1053/j.ajkd.2012.09.018. Epub 2012 Dec 5. Review.

PMID:
23219107
13.

Emerging drugs for diabetic nephropathy.

Bruno S, Cattaneo D, Perico N, Remuzzi G.

Expert Opin Emerg Drugs. 2005 Nov;10(4):747-71. Review.

PMID:
16262561
14.

MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT.

Srivastava SP, Koya D, Kanasaki K.

Biomed Res Int. 2013;2013:125469. doi: 10.1155/2013/125469. Epub 2013 Sep 8. Review.

15.

Exploiting the therapeutic potential of microRNAs in viral diseases: expectations and limitations.

Hemida MG, Ye X, Thair S, Yang D.

Mol Diagn Ther. 2010 Oct 1;14(5):271-82. doi: 10.2165/11539540-000000000-00000. Review.

PMID:
21053993
16.

Changes in the gene expression programs of renal mesangial cells during diabetic nephropathy.

Brunskill EW, Potter SS.

BMC Nephrol. 2012 Jul 28;13:70. doi: 10.1186/1471-2369-13-70.

17.

Molecular mechanisms of diabetic nephropathy and its therapeutic intervention.

Yamagishi S, Fukami K, Ueda S, Okuda S.

Curr Drug Targets. 2007 Aug;8(8):952-9. Review.

PMID:
17691932
18.

Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.

Yang Y, Xiao L, Li J, Kanwar YS, Liu F, Sun L.

Med Hypotheses. 2013 Aug;81(2):274-8. doi: 10.1016/j.mehy.2013.04.031. Epub 2013 May 14.

19.

Inflammatory cytokines in diabetic nephropathy.

Donate-Correa J, Martín-Núñez E, Muros-de-Fuentes M, Mora-Fernández C, Navarro-González JF.

J Diabetes Res. 2015;2015:948417. doi: 10.1155/2015/948417. Epub 2015 Feb 15. Review.

20.

Searching for novel biomarkers and new therapeutic targets of diabetic nephropathy using proteomics approaches.

Thongboonkerd V.

Contrib Nephrol. 2008;160:37-52. doi: 10.1159/000125928. Review.

PMID:
18401160

Supplemental Content

Support Center